Navigation Links
Millennium Enters Into $600,000 Product Development Agreement to Fund Product Development for the $20,000,000 Purchase Agreement with Provider Services, Inc.
Date:1/16/2008

Agreement Provides for Provider Services, Inc. to fund $600,000 for Product Development Associated with the Ready-To-Drink Product to be Developed by

Millennium pursuant to the terms of the $20,000,000 5-year Purchase

Agreement

BASKING RIDGE, N.J., Jan. 16 /PRNewswire/ -- Millennium Biotechnologies Inc., wholly owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG) today announced that it will receive $600,000 in funding pursuant to the terms of a one year Product Development Agreement with Provider Services, Inc. of Cleveland, Ohio (PSI). As Ohio's second largest services provider for the Long Term Care channel, with sales in excess of 300 million dollars, PSI will provide services to over 12,000 residents in 2008.

"Our agreement will allow us to use Millennium's extensive clinical experience and success in the cancer and HIV channels and apply that experience to the nutritional challenges in the Long Term Care channel," stated Mark Mirken, President and Chief Operating Officer of Millennium Biotechnologies.

"Expanding our relationship with MBI and MBTG by funding the product development and providing PSI a one year lead to market on products they provide will give us a significant cost savings and market advantage," Brian Colleran, CEO of PSI stated. Mr. Colleran added, "This will continue to allow us enhance the quality of life for our residents and new tenants."

About Millennium:

Millennium's three proprietary, marketed products, which form the Company's Resurgex(R) Continuum of Care, include Resurgex Select(R), Resurgex(R), and Resurgex Plus(R). Resurgex Select(R) is a whole foods-based, calorically dense, high-protein nutritional formula developed for cancer patients undergoing chemotherapy or radiation treatments. Resurgex(R) and Resurgex Plus(R) are specialized, anabolic nutritional supplements rich in antioxidants that provide nutritional support p
'/>"/>

SOURCE Millennium Biotechnologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Millennium to Webcast Business Update in Advance of 26th Annual JPMorgan Healthcare Conference
2. Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma
3. Millennium Pharmaceuticals Announces Webcast of American Society of Hematology Investor Event
4. Millennium Biotechnologies Inc. Signs Five Year $20,000,000 Purchase Agreement with Provider Services Inc. of Cleveland, Ohio
5. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
6. 2007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation
7. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
8. Synova Healthcare to Participate in Womens Health Care in the New Millennium Conference, as Retail Distribution for the Fem-V(R) Test Kit Expands
9. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
10. Speaking of Womens Health Community Event Returns to All Wal-Mart Supercenters Nationwide January 12th
11. Susan G. Komen for the Cure, Ryan Community Health Centers, Breast Cancer Survivors Call on New York State to Expand Breast Cancer Screening, Treatment Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2015)... Lowcostcarinsuranceprice.com has released a new blog ... drivers arrested for DUI. The blog post also discusses ... . , Some pills can have dangerous side ... who are under medication should ask their doctor’s advice ... can be considered driving under the influence and clients ...
(Date:4/19/2015)... Chicago, IL (PRWEB) April 19, 2015 A ... of medical equipment from a major hospital in Brooklyn, NY ... sold including radiology, surgery, endoscopy, lab, anesthesia, exam and much ... 21 and Wednesday, April 22 starting at 9:00am CDT each ... 1400 N. 25th Avenue, Melrose Park, IL 60160. Anyone ...
(Date:4/18/2015)... For some people, tattoos are works of ... rest of their lives, as they have spent a great ... a great amount of thought on their designs. For others, ... them or simply want them removed for personal or professional ... and in 2012-13 there was a 43 percent increase in ...
(Date:4/18/2015)... 18, 2015 Carinsurancehints.com has released a new ... that offer financial protection against fire damage. , ... benefits in case their vehicle is set intentionally on fire. ... by rioting or by other things. , It is ... a single website http://www.carinsurancehints.com/ , in just a ...
(Date:4/18/2015)... Lowcostcarinsuranceprice.com has released a new blog ... auto insurance prices . , Drivers who ... theft may have to pay more for auto insurance ... policies can also offer protection against vehicle theft. ... online on a single website: http://lowcostcarinsuranceprice.com/ . ...
Breaking Medicine News(10 mins):Health News:Driving On Medication - Possible Effects On Auto Insurance Prices 2Health News:Centurion to Sell Surplus Medical Equipment in Online and On-Site Auction 2Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:Online Auto Insurance Quotes For Plans That Cover Fire Damages! 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2
... , WEDNESDAY, Dec. 28 (HealthDay News) -- State ... up road patrols through Monday, Jan. 2, in an effort ... Highway Safety Association are teaming up with local police forces ... "Any person who considers drinking and driving should know that ...
... HealthDay Reporter , TUESDAY, Dec. 27 (HealthDay News) ... of the body and who are treated with radiation therapy ... that lead to the heart, researchers say. A ... narrowed coronary arteries was more than four times greater for ...
... of nurses and physicians in intensive care units (ICUs) in ... such as excess intensity of care for a patient, was ... sharing, communication and job autonomy, according to a study in ... "Clinicians perceive the care they provide as inappropriate when they ...
... -- Poor people are quicker than middle-class or rich individuals ... according to a new study. It included more than ... part in three experiments designed to assess their levels of ... concluded lower-class people are more likely to react with anxiety ...
... the major arterial blood vessels. It is one of the ... IL-1 has been linked to atherosclerosis and a clinical trial ... is being studied for its effects on the severe clinical ... a team of researchers led by Gary Owens, at the ...
... By Dennis Thompson HealthDay Reporter , TUESDAY, Dec. ... a deep and complex relationship with animals, which elicit a ... interactions with human beings. But these days, animals are ... drastically from traditional notions of animal-assisted therapy. "Most people ...
Cached Medicine News:Health News:States Crack Down on Drunk Drivers This Holiday Season 2Health News:Breast Cancer Radiation Linked to Raised Heart Risk 2Health News:Breast Cancer Radiation Linked to Raised Heart Risk 3Health News:Perception of inappropriate care frequent among ICU workers 2Health News:Perception of inappropriate care frequent among ICU workers 3Health News:Poor People May Be Quicker to Be Kind 2Health News:The New Face of Pet Therapy 2Health News:The New Face of Pet Therapy 3
(Date:4/17/2015)... 2015 CVS Health Corporation (NYSE: CVS ... May 1, 2015, at 8:30 a.m. (EDT) with analysts ... An audio webcast of the conference call ... of the CVS Health website for all interested parties. ... webcast will be archived and available on the web ...
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ... Testing - Global Strategic Business Report" report to ... markets for ADME-Toxicology Testing in US$ Million by the ... Testing. The report provides separate comprehensive analytics ... Japan , Europe , ...
(Date:4/17/2015)... DIEGO , April 17, 2015  Trovagene, ... diagnostics, announced today that clinical data presented at ... that its urine-based Precision Cancer Monitoring ℠ ... and monitoring of EGFR T790M mutations ... Detection of EGFR T790M Mutation in Urinary ...
Breaking Medicine Technology:ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
... Intravenous Recombinant Factor IX (rFIX) Product for the Treatment ... Biopharmaceuticals, Inc., today announced the initiation of a Phase ... Factor IX (rFIX) product for control and prevention of ... is estimated that the market for therapies to treat ...
... the risk of cardiovascular hospitalization or death by 24 ... Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and ... that the ATHENA trial was published in the New ... (dronedarone), in addition to standard therapy, significantly reduced the ...
Cached Medicine Technology:Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B 2New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 2New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 3New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 4New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 5New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 6
Micro emulsifying needles, 18G....
Micro-Scissors "micro 2000". 12 mm, straight, extra-wide serrated handles....
... forceps "micro 2000", with ... tension light-weight instruments with ... extremely light weight, well ... fatigueless working, easy to ...
30 Degree angle....
Medicine Products: